LD
ESRX

Lipe & Dalton’s Express Scripts Holding Company ESRX Stock Holding History

Lipe & Dalton’s Portfolio ESRX Stock Details ESRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-12,775
Closed -$1.21M – 72
2018
Q3 		$1.21M Sell
12,775
-13,395
-51% -$1.14M 0.83% 43
2018
Q2 		$2.02M Buy
26,170
+30
+0.1% +$2.25K 1.49% 27
2018
Q1 		$1.81M Buy
26,140
+2,630
+11% +$201K 1.29% 31
2017
Q4 		$1.75M Buy
23,510
+10,850
+86% +$694K 1.21% 32
2017
Q3 		$802K Buy
+12,660
New +$787K 0.56% 40

Other funds holding ESRX

SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
BSPF
British Steel Pension Fund London, United Kingdom $410M AUM 11.96% 1-Year Est. Return
MYAM
Meiji Yasuda Asset Management Tokyo, Japan $2B AUM 22.52% 1-Year Est. Return
AWM
Alterna Wealth Management Houston, Texas $174M AUM 15.45% 1-Year Est. Return
W
Wealthquest Cincinnati, Ohio $1.59B AUM 18.1% 1-Year Est. Return
ACA
Atlas Capital Advisors Jackson, Wyoming $875M AUM
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
SBL
Sargent Bickham Lagudis Boulder, Colorado $1.22B AUM 14.94% 1-Year Est. Return

Lipe & Dalton's ESRX Position: Q4 2018 in Review

Lipe & Dalton sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 12,775 shares — an estimated $1.21M sold.

Lipe & Dalton first reported a position in ESRX in Q3 2017 and held it in 5 quarters. The position peaked at $2.02M in Q2 2018. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

  • Lipe & Dalton reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
  • Lipe & Dalton sold 12,775 Express Scripts Holding Company shares in Q4 2018, an estimated $1.21M.
  • Lipe & Dalton first reported a position in Express Scripts Holding Company in Q3 2017 and held it in 5 quarters.
  • Lipe & Dalton's Express Scripts Holding Company position peaked at $2.02M in Q2 2018.
  • 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on Lipe & Dalton's 13F filing for Q4 2018, filed 8 Feb 2019.